UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045509
Receipt number R000051960
Scientific Title Effect of individualized occupational therapy on everyday functioning in patients with schizophrenia: A 5-year follow-up of a randomized controlled trial
Date of disclosure of the study information 2021/09/17
Last modified on 2022/10/20 10:35:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of individualized occupational therapy on everyday functioning in patients with schizophrenia: A 5-year follow-up of a randomized controlled trial

Acronym

Effect of individualized occupational therapy on everyday functioning in patients with schizophrenia

Scientific Title

Effect of individualized occupational therapy on everyday functioning in patients with schizophrenia: A 5-year follow-up of a randomized controlled trial

Scientific Title:Acronym

Effect of individualized occupational therapy on everyday functioning in patients with schizophrenia

Region

Japan


Condition

Condition

Schizophrenia

Classification by specialty

Psychiatry Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test the effect of individualized occupational therapy on everyday functioning in patients with schizophrenia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Real-world functioning

Key secondary outcomes

Cognition
Intrinsic motivation
Psychiatric symptom


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) 20-65 years of age
(2) newly hospitalized in a psychiatric hospital and discharged within 1 year
(3) diagnosed with schizophrenia or schizoaffective disorder based DSM-5

Key exclusion criteria

(1) a current primary DSM-5 diagnosis other than schizophrenia or schizoaffective disorder
(2) a history of mental retardation
(3) a history of neurological disorder
(4) a history of significant drug or alcohol abuse
(5) comorbid serious physical disorder

Target sample size

109


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

386-0401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268-35-0305

Email

ot@seitaikai.or.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

386-0401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268-35-0305

Homepage URL


Email

ot@seitaikai.or.jp


Sponsor or person

Institute

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Institute

Department

Personal name



Funding Source

Organization

Japanese Association of Occupational Therapists

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

Tel

0268-35-0305

Email

ot@seitaikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

109

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 06 Day

Date of IRB

2015 Year 10 Month 06 Day

Anticipated trial start date

2016 Year 02 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2021 Year 09 Month 17 Day

Last modified on

2022 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051960


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name